Aktive Positionen von Jennifer Viera
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ENANTA PHARMACEUTICALS, INC. | Investor Relations Kontakt | 01.01.2023 | - |
| Public Communications Contact | 01.01.2023 | - |
Karriereverlauf von Jennifer Viera
Ehemalige bekannte Positionen von Jennifer Viera
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
OvaScience, Inc.
 OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Corporate Officer/Principal | - | - |
| TETRAPHASE PHARMACEUTICALS, INC. | Investor Relations Kontakt | - | - |
| Public Communications Contact | - | - |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Investor Relations Contact | 2 |
| Public Communications Contact | 2 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ENANTA PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetraphase Pharmaceuticals, Inc. is engaged in the development and production of novel tetracyclines for serious and life-threatening bacterial infections. It also develops eravacycline, a synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Waltham, MA. | Health Technology |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Health Technology |
- Börse
- Insiders
- Jennifer Viera
- Erfahrung
